Search
Scilex Holding Co
SCLXAdd to Watchlist
6.665USD
+0.065+0.98%
Close 07-31 16:00（ET）Quotes delayed by 15 min
46.87MMarket Cap
LossP/E TTM
More Details of Scilex Holding Co Company
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
Scilex Holding Co Info
Ticker SymbolSCLX
Company nameScilex Holding Co
IPO dateJan 11, 2021
CEOJi (Henry H)
Number of employees115
Security typeOrdinary Share
Fiscal year-endJan 11
Address960 San Antonio Road
CityPALO ALTO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94303
Phone16505164310
Websitehttps://www.scilexholding.com/
Ticker SymbolSCLX
IPO dateJan 11, 2021
CEOJi (Henry H)
Company Executives of Scilex Holding Co
Name
Name/Position
Position
Shareholding
Change
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
19.37K
-0.42%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
--
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
--
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
19.37K
-0.42%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
--
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
--
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
--
--
FAQs
Who are the top five shareholders of Scilex Holding Co?
The top five shareholders of Scilex Holding Co are: Dr. Henry H. Ji, Ph.D.
How many institutions hold shares of Scilex Holding Co (SCLX)?
As of 2026Q1, 258 institutions hold shares of Scilex Holding Co, with a combined market value of approximately 1.44M, accounting for 16.97% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 401365.00.